RT Journal Article SR Electronic T1 Incidence and clinical importance of bone marrow eosinophilia in Hodgkin's disease (BNLI Report No 29). British National Lymphoma Investigation. JF Journal of Clinical Pathology JO J Clin Pathol FD BMJ Publishing Group Ltd and Association of Clinical Pathologists SP 245 OP 246 DO 10.1136/jcp.40.3.245 VO 40 IS 3 A1 E A Macintyre A1 B Vaughan Hudson A1 G Vaughan Hudson A1 A M Jelliffe A1 D C Linch YR 1987 UL http://jcp.bmj.com/content/40/3/245.abstract AB A retrospective study of 136 bone marrow aspirates was undertaken before treatment to evaluate the importance of bone marrow eosinophilia in Hodgkin's disease. This occurred in 28 patients (21%) but did not correlate with age, sex, B symptoms, histopathological type or peripheral blood count. It also had no effect on survival. Bone marrow eosinophilia, therefore, seems to represent a common but non-specific reaction to Hodgkin's disease.